Sally Temple: Difference between revisions

Content deleted Content added
CKnudson7 (talk | contribs)
m Additions to research were made. Awards were listed under photograph.
m Removing from Category:American women scientists Diffusing per WP:DIFFUSE using Cat-a-lot
 
(25 intermediate revisions by 16 users not shown)
Line 1:
{{short description|American neuroscientist}}
{{Infobox scientist
| name = Sally Temple
| native_name =
| native_name_lang =
| image = Temple sally download 2.JPG
| imagesize =
| alt =
Line 18 ⟶ 19:
| citizenship =
| nationality = American
| fields = [[neuroscienceNeuroscience]]
| workplaces = [[Albany Medical College]]
| patrons =
Line 32 ⟶ 33:
| influences =
| influenced =
| awards = [[MacArthur Fellows Program]]
[[Jacob Javitz Merit Award]]
[[Citizen Laureate Awards]]Award
| author_abbrev_bot =
| author_abbrev_zoo =
Line 45 ⟶ 46:
| footnotes =
}}
 
'''Sally Temple''' is aan American developmental [[neuroscientist]] in [[Albany, New York]]. She is a co-founder and thescientific Scientificdirector Director of [http://www.neuralsci.orgfor The Neural Stem Cell Institute] and Professoris a professor of [[Neuroscience]] and [[Neuropharmacology]] at [[Albany Medical College]]<ref name=":2">{{Cite web|title = Sally Temple, Ph.D., Scientific Director - Neural Stem Cell Institute, Rensselaer NY|url = http://neuralsci.org/about-us/our-team/sally-temple-scientific-director-neural-stem-cell-institute|website = Neural Stem Cell Institute, Rensselaer NY|accessdate = 2015-11-19|language = en-US}}</ref> Dr. Temple is also the principal investigator in her lab. Thislaboratory labthat focuses on neural stem cells and therapies for neurological-related disorders<ref name=":0">{{Cite web|title = Sally Temple - StemCulture|url = http://stemcultures.com/sally-temple/|website = StemCulture|accessdate = 2015-11-19|language = en-US}}</ref>
 
==Life==
Dr. Sally Temple received her B.A. from [[Cambridge University]]. She then continued her PhD education at the [[University College London]] and competed her postdoctoral fellowship at [[Columbia University]]. Her focus at this time was on optic nerve development.<ref name=":0" />.
 
Dr. Temple became a pioneer in the field of [[stem cell]] research when she discovered that the embryonic mammalian brain contained a rare stem-like cell. After this discovery, she focused on [[neural stem cellscell]]s and how they develop over time and produce progeny.<ref name=":0" />.
 
Dr. TempleShe has since been labelled as an innovator in the field of [[stem cells]], specifically [[neural stem cell]]s, which are potentially applicable in [[cell replacement therapy]] for ailments like [[spinal cord injury]] and [[neurodegeneration]]. She is the president and co-founder of StemCulture, LLC., a company created by scientists in order to create innovative products and promote scientific research.<ref name=":1" />
 
In 2010 she and John J. Nigro were recipients of the 2010 Citizen Laureate Awards. This award is meant to recognize leaders in the fields of business, industry, government, and academia.<ref name=":1">{{Cite web|title = Stem Cell Researcher Made University at Albany Citizen Laureate - University at Albany-SUNY|url = http://www.albany.edu/news/10149.php|website = www.albany.edu|accessdate = 2015-11-19}}</ref>.
 
Previously, she was a fellow of the [[Alden March Bioethics Institute]].<ref name=":3" />.
 
Temple currently is the scientific director of the [http://neuralsci.org Neural Stem Cell Institute]. She also is a faculty member for [[Albany Medical College]], [[Rensselaer Polytechnic Institute]], and [[University at Albany, SUNY|SUNY Albany]].<ref name=":3" /> Dr. Temple is married to Dr. Jeffrey Stern, a retinal surgeon, who is the other co-founder of the Regenerative Research Foundation and Neural Stem Cell Institute.<ref>{{Cite web|title = Jeffrey Stern - StemCulture|url = http://stemcultures.com/jeffrey-stern/|website = StemCulture|accessdate = 2015-11-20|language = en-US}}</ref>
== Research ==
Dr. Temple's current laboratory focuses primarily on neural stem cells and the development for therapies related to eye, brain, and spinal cord disorders<ref name=":0" />.
 
She is a member of the Editorial Board for ''[[Developmental Cell]]''.
She has made many important accomplishments in the field of neuroscience.
 
== Research ==
One of these accomplishments is the isolation and culturing of a progenitor cell line of glia, that indicated the number of cell divisions the cell underwent was determined by internal counting mechanisms<ref name=":3" />. This research also led to her indicating specific markers on progenitor cell lines and external signaling molecules that are involved in the maintenance of neural stem cells<ref name=":2" />.
Dr. Temple's current laboratory focuses primarily on neural stem cells and the development for therapies related to eye, brain, and spinal cord disorders.<ref name=":0" />.
 
One of theseher major accomplishments in her field is the isolation and culturing of a [[Progenitor cell|progenitor cell line]] of [[Neuroglia|glia,]]. that indicatedThis led to the discovery that the number of cell divisions the cell underwent was determined by internal counting mechanisms.<ref name=":3" />. This research also led to her indicating specific markers on progenitor cell lines and external signaling molecules that are involved in the maintenance of neural stem cells.<ref name=":2" />.
Some of her other research has indicated that the limited success of embryonic stem cell transplants in neurological cases may be due to the introduction of cells at the wrong developmental stage. This may have a huge impact on neurological therapies using stem cells as a future of medicine<ref name=":2" />.
 
Some of her other research has indicated that the limited success of embryonic stem cell transplants in neurological cases may be due to the introduction of cells at the wrong developmental stage. This may have a huge impact on neurological therapies using stem cells as a future of medicine.<ref name=":2" />.
She has also provided evidence in her field that has shown that progenitor cells gradually lose the ability to divide. The ''[[FOXG1|Foxg1]]'' [[FOXG1|gene]] is important in this, because a reduction in it's expression results in a delay in this process<ref name=":3" />.
 
She has also provided evidence in her field that has shown that progenitor cells gradually lose the ability to divide. TheShe established that the ''[[FOXG1|Foxg1]]'' [[FOXG1|gene]] is important in this, because a reduction in it'sits expression results in a delay in this process.<ref name=":3" />.
As president of StemCulture, LLC. she is currently working on a new study involved a new product, StemBeads FGF2<ref name=":0" />.
 
As president of StemCulture, LLC. she is currently working on a new study involving a new product, StemBeads FGF2.<ref name=":0" /> StemCulture, LLC. describe this product as a [[growth factor]] supplement that is able to grow [[FGF2]] dependent stem cell cultures in a more efficient way.<ref>{{Cite web|title = You searched for stem beads fgf2 - StemCulture|url = http://stemcultures.com/?s=stem+beads+fgf2|website = StemCulture|accessdate = 2015-11-20|language = en-US}}</ref> She also recently identified an important human central nervous stem cell that may lead to important developments in retinal disease treatments.<ref>{{Cite web|title = Speaker - Cell Symposia: Stem cells in modeling and treating disease, November 21 - 23, 2013 Cedars-Sinai Medical Center, Los Angeles, USA|url = http://www.cell-symposia-stemcells-modelingtreatingdisease.com/bio-temple.html|website = www.cell-symposia-stemcells-modelingtreatingdisease.com|access-date = 2015-11-20|url-status = dead|archive-url = https://web.archive.org/web/20151120103626/http://www.cell-symposia-stemcells-modelingtreatingdisease.com/bio-temple.html|archive-date = 2015-11-20}}</ref> In 2015, she attended a RPI stem cell and bioengineering meeting and spoke about her [[Retinal pigment epithelium|retinal pigmented epithelial]] (RPE) research. She discussed how her team has been furthering their research into culturing human retinal stem cells and the use of RPE cells in therapy for age-related [[macular degeneration]].<ref>{{Cite web|title = Sally Temple on adult RPEs for vision impairment, IND, & more - The Niche|url = https://www.ipscell.com/2015/06/sally-temple/|website = The Niche|date = 17 June 2015|accessdate = 2015-11-20|language = en-US}}</ref>
Her research has been published in multiple scientific journals<ref name=":0" />
 
=== Patents ===
Temple has a large number of patents related to neural stem cells and for various methods for culture undifferentiated cells.<ref>{{Cite web|title = Patents by Inventor Sally Temple Stern - Justia Patents Database|url = http://patents.justia.com/inventor/sally-temple-stern|website = patents.justia.com|accessdate = 2015-11-20}}</ref>
 
== Awards ==
2008In -2003 Dr. Temple received the Jacob Javitz Merit Award from the [[National Institutes of Health|National Institute of Health]].<ref name=":0" /> She was then awarded the [[MacArthur Fellows Program|MacArthur Fellowship]] -in Dr2008. Temple wasThis awardedaward in considered thisa no-strings attached grant intended to supplement the winner's potential for creativity.<ref name=":3">{{Cite web|title = Sally Temple — MacArthur Foundation|url = https://www.macfound.org/fellows/813/|website = www.macfound.org|accessdate = 2015-11-19}}</ref> Dr. Temple was also the recipient of the 2010 Citizen Laureate Awards. This was awarded to her by The University at Albany Foundation for her research into treatments for both macular degeneration and [[Parkinson's disease]].<ref name=":1" />
2003 - Jacob Javitz Merit Award - Awarded from [[National Institutes of Health|NIH]]<ref name=":0" />
 
== Publications ==
2008 - [[MacArthur Fellows Program|MacArthur Fellowship]] - Dr. Temple was awarded this no-strings attached grant intended to supplement the winner's potential for creativity<ref name=":3">{{Cite web|title = Sally Temple — MacArthur Foundation|url = https://www.macfound.org/fellows/813/|website = www.macfound.org|accessdate = 2015-11-19}}</ref>
* ''Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure.'' Phoenix TN, Temple S. Genes Dev. 2010 Jan 1;24(1):45-56.
 
* ''The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells.'' Shen Q, Wang Y, Dimos JT, Fasano CA, Phoenix TN, Lemischka IR, Ivanova NB, Stifani S, Morrisey EE, Temple S. Nat Neurosci. 2006 Jun;9(6):743-51. Epub 2006 May 7.
2010 - Citizen Laureate Awards - Awarded from The University at Albany Foundation<ref name=":1" />
* ''LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1.'' Capela A, Temple S. Dev Biol. 2006 Mar 15;291(2):300-13. Epub 2006 Feb 3.
* ''Asymmetric distribution of EGFR receptor during mitosis generates diverse CNS progenitor cells.'' Sun Y, Goderie SK, Temple S. Neuron. 2005 Mar 24;45(6):873-86.
* ''LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal.'' Capela A, Temple S. Neuron. 2002 Aug 29;35(5):865-75.
 
== References ==
{{reflistReflist}}
 
== External links ==
* [http://www.neuralsci.org The Neural Stem Cell Institute]
 
{{Authority control}}
 
{{DEFAULTSORT:Temple, Sally}}
Line 88 ⟶ 101:
[[Category:Alumni of University College London]]
[[Category:American neuroscientists]]
[[Category:WomenAmerican women neuroscientists]]
[[Category:American women scientists]]
[[Category:Columbia University alumni]]
[[Category:MacArthur Fellows]]
[[Category:Year of birth missing (living people)]]
 
[[Category:21st-century American women scientists]]
 
[[Category:Members of the National Academy of Medicine]]
{{bio-stub}}